Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × apaziquone × Clear all

NCT00141531 2012-06-14

Phase II Trial of EOquin in High-risk Superficial Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma in Situ